Digital Health
Webinar: Synthesise RWE and AI. Transform patient-driven healthcare
Channels: Access and EvidencePermission: FreeDescription: As the volume of the real word evidence data increases, the mechanisms to collect and translate…
The application of AI in the generation of RWE has significant potential to improve drug discovery, optimise trial design, and identify patient treatment pathways – but pharma need to overcome hurdles of streaming data into standardised models, data quality, and interpretation of diverse data sets if it is to succeed in building trust in RWE.
AI offers pharma the opportunity to streamline data, accelerate RWE adoption, and positively impact patient outcomes. Join this webinar to learn how to:
- Decipher underutilised RWE data through AI to positively impact patient and pharma outcomes
- Leverage AI to draw meaningful insights and patterns that enhance drug discovery, identify risk, improve patient pathways, adherence monitoring and patient behaviour.
- Overcome challenges of standardisation, organisation, analysis and interpretation to maximise RWE’s benefits and revolutionise patient-driven healthcare
Find out more about gaining competitive advantage with Cegedim Health Data.
Keep it Short
By KIM BELLARD OK, I admit it: I’m on Facebook. I still use Twitter – whoops, I mean X. I have an Instagram account but don’t think I’ve ever posted….
Asian Fund for Cancer Research announces Degron Therapeutics as the 2023 BRACE Award Venture Competition Winner
The Asian Fund for Cancer Research (AFCR) is pleased to announce that Degron Therapeutics was selected as the winner of the 2023 BRACE Award Venture Competition….
Seattle startup Olamedi building platform to automate health clinic communications
A new Seattle startup led by co-founders with experience in health tech is aiming to automate communication processes for healthcare clinics with its software…
